Biotechnology News

September 10, 2012

BOSTON--(BUSINESS WIRE)--Acetylon will participate in an epigenetics panel at the Rodman and Renshaw Healthcare Conference and give a corporate presentation at BioPharm America 2012.

September 10, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics’ CEO To Present at the Rodman and Renshaw Annual Global Investment Conference

September 10, 2012

WOBURN, Mass.--(BUSINESS WIRE)--AdvanDx, Inc. today announced the commercial launch of QuickFISH™, a new rapid pathogen identification test for potential life threatening bloodstream infections.

September 10, 2012

WESTON, Mass. & TORONTO--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and DRI Capital today announced that Biogen Idec has sold to a DRI Capital managed fund (DRI) its royalty and other rights relating to BENLYSTA® (belimumab) to which Biogen...

September 10, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) announced today that the combination of bortezomib (the active component of VELCADE® marketed by Millennium, The Takeda Oncology Company)...

September 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s CEO, is...

September 10, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River to present at Morgan Stanley healthcare conference

September 10, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma today announced the appointment of Thomas Pitler, Ph.D. as vice president of business development.

September 10, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tobira expands senior management team with key hires as it advances cenicriviroc into late-stage studies for the treatment of HIV infection.

September 10, 2012

ATLANTA--(BUSINESS WIRE)--IPG, the leading nationwide provider of Device Benefit Management solutions, to showcase Implantable Device Savings Analytics Platform at 2012 Blue National Summit

September 10, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Adam H. Schechter, executive vice president and president, Global Human Health is scheduled to present at the...

September 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced top line results from its...

September 10, 2012

PERKASIE, Pa.--(BUSINESS WIRE)--On September 19, Peter D. Gabriele, Director of Emerging Technology at Secant Medical, Inc., will present at the MEDevice 2012 Design of Implantable Devices Forum in San Diego, California.

September 10, 2012

NESS ZIONA, Israel--(BUSINESS WIRE)--Atox Bio, a clinical stage biotechnology company engaged in the development of novel immunemodulators for severe infections in critically ill patients, announced today that the U.S. Food and Drug...

September 10, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Durata Therapeutics announced data at ICAAC demonstrating dalbavancin's potency against numerous significant bacterial isolates. Dalbavancin is in Phase 3 clinical trials for the treatment of ABSSSI.

September 10, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX advances proteomics research with Eksigent nano LC System

September 10, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa President and CEO to participate in upcoming industry conferences. Keynote speaker at IPO Association annual meeting and panelist at Burrill Personalized Medicine conference.

September 10, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) announced today that pre-clinical findings presented at the 3rd European Congress of Immunology provide additional support for the potential of CGEN-15001 to effectively treat...

September 10, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. announced today that oral administration of two of its FluCide™ anti-influenza drug candidates was superior to oseltamivir (Tamiflu®, Roche) in a highly lethal animal model.

September 10, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ) announced today that it has received the decision in the confidential arbitration with Atomic Energy of Canada Limited (AECL). Nordion was unsuccessful in its claim for...

September 10, 2012

BOSTON--(BUSINESS WIRE)--At the 11th HUPO Annual World Congress the MacCoss lab of Biological Mass Spectrometry at the University of Washington in Seattle introduces a new version of Skyline Software, now supporting Bruker maXis™ series ultra-...

September 10, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it has appointed Paul Bianchi as Senior Vice President of Human Resources. In this executive management position, Bianchi will oversee Illumina’s global HR strategy and...

September 10, 2012

DENVER--(BUSINESS WIRE)--The new DaVita® Contact Center serves patients across the country, taking and placing calls to and from doctors, hospitals, patients and family members to help match both visiting and new patients.

September 10, 2012

NETANYA, Israel--(BUSINESS WIRE)--High reported rates of repeat lumbar discectomy surgery suggest a pressing need for improvements in technique, technology, and outcomes for patients requiring this procedure.

September 10, 2012

RICHMOND, Va. & LONDON & SYDNEY--(BUSINESS WIRE)--AmpliPhi announces its offer to acquire Special Phage Services which would result in the creation of an company focused on developing phage-based therapies to combat antibiotic-resistant...

September 10, 2012

NAARDEN, The Netherlands & MUNICH, Germany & BOSTON--(BUSINESS WIRE)--Forbion Announces Appointment of Philip Astley-Sparke as Venture Partner

September 7, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Algenist, the luxury, anti-aging skincare brand offering the key ingredient Alguronic Acid®, is scheduled for its one-hour QVC® debut on September 8, 2012 at 3 PM (ET). Launched on QVC and in Sephora in March 2011...

September 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, a leader in the development of innovative gene therapies for severe genetic disorders, announced today that Jeffrey T. Walsh, chief operating officer, is scheduled to present at the Rodman &...

September 7, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has entered into an exclusive supply agreement with LipoScience Inc. to provide nuclear magnetic resonance (NMR) components for LipoScience’s...

September 7, 2012

--(BUSINESS WIRE)--hTEE provides real-time imaging of the heart through the Zura system and miniaturized ClariTEE probe (indwelling for up to 72 hours) to improve ICU patient outcomes and reduce healthcare costs.

September 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., chief executive officer of...

September 7, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision has completed enrollment of its Phase 3 DOUBle clinical trial evaluating AzaSite Plus and DexaSite in a single study for the treatment of blepharitis.

September 7, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that ACT’s chairman and CEO Gary Rabin will be presenting at the 14th Annual Rodman &...

September 7, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced that it has settled its litigation against Mylan Inc. and Mylan Pharmaceuticals Inc. relating to Pfizer’s patents covering Detrol LA® (tolterodine tartrate) extended-release capsules. As a result...

September 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present on its focal adhesion kinase program at the 11th International Conference of the International Mesothelioma Interest Group on September 12, 2012, in Boston, MA.

September 7, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an...

September 7, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: A retrospective sequential analysis of 311 premature infants, born with a weight below 1000 grams, showed that prophylactic supplementation of Lactobacillus reuteri Protectis resulted in a...

September 7, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics (STO:PREC): Shareholders in Precise Biometrics have a preferential right to subscribe two (2) new shares for five (5) existing shares on the record day September 17, 2012. The...

September 7, 2012

IRVINE, Calif.--(BUSINESS WIRE)--QUALITY SYSTEMS, INC. TO PRESENT AT THE MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCE

September 6, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 12, 2012 at 1:00 p.m. ET and the ThinkEquity 9th Annual...

September 6, 2012

FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, a clinical‐stage biopharmaceutical company discovering and developing novel, small molecule, best‐in‐class compounds, today announced the presentation of promising preclinical in vivo...

September 6, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--KaloBios Completes Debt Financing of Up to $15 Million following $20.25 Million in Gross Equity Raised in Second Quarter.

September 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2012 at 2:10 p.m. Eastern Time at the Grand Hyatt New York. A live...

September 6, 2012

LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories Inc. (Nasdaq: CBRX) received a notice on September 6, 2012, from the Nasdaq Stock Market indicating that the Company has regained compliance with the minimum bid price requirement for...

September 6, 2012

WELLESLEY HILLS, Mass.--(BUSINESS WIRE)--BioBridges, LLC, a clinical development consultancy serving the biopharmaceutical community, announced today the appointment of Warren Steinberg, M.B.A., to Controller. Mr. Steinberg will help to guide the...